About Greg Keenan
Form D filings for Hubble Therapeutics in 2024 list Greg Keenan as director.
Greg Keenan first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Greg Keenan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Greg Keenan works with at each company, as listed on that company's latest Form D.
Hubble Therapeutics, LLC · Form D, Oct 21, 2024
JS
Jeff Sabados
Chief Executive Officer and director
SG
Sam Goldberger
Director